U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H23ClN4O2.C4H4O4
Molecular Weight 442.894
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of DAZOPRIDE FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.CCN1CC(CN1CC)NC(=O)C2=C(OC)C=C(N)C(Cl)=C2

InChI

InChIKey=IGGKTAIAQUIFKQ-WLHGVMLRSA-N
InChI=1S/C15H23ClN4O2.C4H4O4/c1-4-19-8-10(9-20(19)5-2)18-15(21)11-6-12(16)13(17)7-14(11)22-3;5-3(6)1-2-4(7)8/h6-7,10H,4-5,8-9,17H2,1-3H3,(H,18,21);1-2H,(H,5,6)(H,7,8)/b;2-1+

HIDE SMILES / InChI

Molecular Formula C15H23ClN4O2
Molecular Weight 326.822
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Dazopride is an antagonist of the 5-HT3 receptor and agonist of the 5-HT4 receptor, structurally related to metoclopramide. Dazopride was developed by A. H. Robins Company as an antiemetic and gastroprokinetic drug. Dazoptide demonstrated an antiemetic effect in the clinic after i.v. infusion to patients, receiving anticancer therapy.

Approval Year

Patents

Patents

Sample Use Guides

i.v. infusions every 2 h beginning 30 min before the chemotherapy at doses 0.5 to 4.0 mg/kg.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:26:52 UTC 2023
Edited
by admin
on Fri Dec 15 15:26:52 UTC 2023
Record UNII
J8ZC30U6CH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DAZOPRIDE FUMARATE
USAN   WHO-DD  
USAN  
Official Name English
AHR-5531C
Code English
4-Amino-5-chloro-N-(1,2-diethyl-4-pyrazolidinyl)-O-anisamide fumarate (1:1)
Common Name English
DAZOPRIDE FUMARATE [USAN]
Common Name English
BENZAMIDE, 4-AMINO-5-CHLORO-N-(1,2-DIETHYL-4-PYRAZOLIDINYL)-2-METHOXY-, (E)-2-BUTENEDIOATE (1:1)
Systematic Name English
Dazopride fumarate [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C267
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
Code System Code Type Description
MESH
C047339
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
CAS
81957-25-7
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
NCI_THESAURUS
C74146
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
FDA UNII
J8ZC30U6CH
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
PUBCHEM
11954360
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
USAN
T-114
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
ChEMBL
CHEMBL2110810
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
EPA CompTox
DTXSID50231483
Created by admin on Fri Dec 15 15:26:52 UTC 2023 , Edited by admin on Fri Dec 15 15:26:52 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY